Clinical Trial Update: Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating attenuation of hemodynamic responses to laryngoscopy using dexmedetomidine in the context of tracheal intubation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemodynamic Instability
• Tracheal Intubation Complications

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Sindh Institute of Urology and Transplantation | Conditions: Hemodynamic Instability, Tracheal Intubation | Phase 4 | Status: COMPLETED